Table 2:

Selected ProFit-quantified metabolite ratios (mean ± SD) calculated from predominantly the occipital and medial frontal gray matter regions and the prefrontal WM (left) of 9 patients with OSA and 11 healthy controls

Metabolite RatiosOccipital Gray MatterMedial Frontal Gray MatterLeft Frontal White Matter
OSAHCOSAHCOSAHC
tNAA1.793 ± 0.39a2.158 ± 0.540.949 ± 0.26a1.268 ± 0.171.190 ± 0.281.323 ± 0.31
Glx1.637 ± 0.411.451 ± 0.581.531 ± 0.481.289 ± 0.491.658 ± 0.401.661 ± 0.45
tCho0.192 ± 0.05a0.252 ± 0.090.317 ± 0.080.346 ± 0.090.236 ± 0.05a0.346 ± 0.06
NAA1.510 ± 0.421.893 ± 0.430.744 ± 0.30a1.052 ± 0.250.904 ± 0.260.950 ± 0.28
mIns0.634 ± 0.280.493 ± 0.211.792 ± 0.651.536 ± 0.421.545 ± 0.311.496 ± 0.39
Tau0.140 ± 0.0a0.421 ± 0.200.627 ± 0.240.906 ± 0.370.341 ± 0.12a0.826 ± 0.38
sI0.038 ± 0.01a0.052 ± 0.010.099 ± 0.040.117 ± 0.050.073 ± 0.020.102 ± 0.03
GPC0.160 ± 060.169 ± 0.070.181 ± 0.100.210 ± 0.090.170 ± 0.100.135 ± 0.09
PCh0.064 ± 0.02a0.125 ± 0.050.079 ± 0.020.151 ± 0.040.228 ± 0.090.076 ± 0.048
  • Note:—HC indicates healthy controls; GPC, glycerylphosphocholine; PCh, phosphocholine; sI, scyllo-Inositol; Tau, taurine.

  • a P < .0.5.